Casein Kinase 1α—A Target for Prostate Cancer Therapy?
The androgen receptor (AR) is a key driver of prostate cancer (PCa) and, as such, current mainstay treatments target this molecule. However, resistance commonly arises to these therapies and,...
mdpi.com